Revolutionizing Oncology Care
A biotech therapeutics platform focused on immune activation and oncology innovation, expanding global access to oncology care through scalable, low-toxicity immunotherapies.
Innovating for Global Oncology Access
NeoOnco, Inc is a biotech therapeutics platform dedicated to immune activation and oncology innovation. Our mission is to expand global access to oncology care through scalable, low-toxicity immunotherapies—activating systemic immunity with a novel oral format designed for underserved regions. Founded to address the global cancer access bottleneck, we leverage mucosal immune priming and GRAS bacterial vectors to deliver tumor-associated antigens in a format designed for accessibility and scale. With a defensible IP moat and GMP-ready formulation, NeoOnco is positioned for high-value exit at Phase 1B/2.
Transforming Oncology
At NeoOnco, Inc, we offer a comprehensive suite of services designed to revolutionize oncology care. Our focus is on the development of IP-protected immunotherapy protocols, strategic partnerships, digital companion integration, and regulatory and clinical advisory. Each of our services is designed with the goal of expanding global access to oncology care, particularly in underserved regions.
Immunotherapy Protocols Development
Our team of experts develops IP-protected immunotherapy protocols that specifically target antigen-positive cancers. These protocols leverage our deep expertise in biotech governance, regulatory strategy, and IP origination. Our innovative approach allows us to create effective and scalable solutions for cancer treatment.
Licensing and Strategic Partnerships
We offer licensing for clinical deployment across oncology networks and NGOs. Additionally, we form strategic partnerships with Contract Development and Manufacturing Organizations (CDMOs), pharmaceutical companies, and academic institutions. These collaborations enable us to broaden our reach and impact in the oncology field.
Digital Companion Integration
We integrate digital companions into our services for adherence tracking and biomarker capture. This technology allows us to optimize real-world data and adherence, providing valuable insights that can be used to improve patient outcomes.
Regulatory and Clinical Advisory
We provide regulatory and clinical advisory services for deployment in Low and Middle Income Countries (LMIC) and post-chemotherapy settings. Our team of experts ensures that our solutions meet the highest standards of safety and efficacy, providing guidance and support throughout the deployment process.
Why Choose NeoOnco
NeoOnco, Inc is not just another biotech company. We are a team of innovators, researchers, and strategists dedicated to expanding global access to oncology care. Our unique approach, patent-protected technology, and commitment to cost-effective solutions set us apart in the industry.
Patent-Protected Technology
Our patent-protected checkpoint alternative with antigen-swapping capability is a game-changer in the field of oncology. This unique technology allows us to target antigen-positive cancers more effectively, offering a new hope for patients worldwide.
Modular Platform
Our modular platform is designed for flexibility and rapid response. It enables multi-indication expansion and rapid trial deployment, ensuring we can quickly adapt to new research findings, emerging needs in the field, and the unique requirements of different regions and patient populations.
Cost-Effective Solutions
We believe that access to oncology care should not be a privilege of the few, but a right of all. That’s why we’ve developed a shelf-stable, self-administered format with a projected cost of less than $10K. This makes our solutions not only innovative but also accessible and affordable.
Strategic Exit Pathways
We have a clear vision for the future. By 2028, we aim to provide strategic exit pathways via licensing, co-development, or acquisition. This forward-thinking approach ensures the sustainability and long-term impact of our work.
Digital Companion Optionality
We leverage technology to optimize our services. Our digital companion optionality allows for real-world data capture and adherence optimization, providing valuable insights that can be used to improve patient outcomes and refine our solutions.
Get in Touch with NeoOnco, Inc
At NeoOnco, Inc, we’re committed to transforming oncology care through our innovative solutions. Whether you’re interested in our services, want to explore partnership opportunities, or simply have questions about our work, we’re here to help. Reach out to us today to learn more about how we can revolutionize oncology care together.
Email: info@neooncobio.co
Phone number: +1 775-244-2790
Business Hours: Our team is available from Monday to Friday, 9:00 AM – 6:00 PM PT. We strive to respond to all inquiries as quickly as possible within these hours.
We appreciate your interest in NeoOnco, Inc and look forward to connecting with you.
